The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1270
ISSUE1270
September 24, 2007
Fentanyl Buccal Tablet (Fentora) for Breakthrough Pain
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Fentanyl Buccal Tablet (Fentora) for Breakthrough Pain
September 24, 2007 (Issue: 1270)
The FDA has approved a transmucosal tablet formulation of fentanyl citrate (Fentora - Cephalon) for management of breakthrough pain in opioid-tolerant patients with cancer. An oral transmucosal fentanyl lozenge on a stick (Actiq, and others) is also...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.